Showing results (461-470 of 646) with videos related to

Sort By:
Pageof 65
Journal of the American Heart Association|March 5, 2015
Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trialDaniel E Singer, Anne S Hellkamp, Zhong Yuan, et al.
Circulation. Cardiovascular Quality and Outcomes|November 12, 2020
Cause of Death Among Patients With Peripheral Artery Disease: Insights From the EUCLID TrialAjar Kochar, Hillary Mulder, Frank W Rockhold, et al.
American Heart Journal|September 20, 2015
Rationale and design of the Prospective LongitudinAl Trial of FFRCT: Outcome and Resource IMpacts studyGianluca Pontone, Manesh R Patel, Mark A Hlatky, et al.
JACC. Cardiovascular Interventions|January 7, 2022
1-Year Outcomes of Blinded Physiological Assessment of Residual Ischemia After Successful PCI: DEFINE PCI TrialManesh R Patel, Allen Jeremias, Akiko Maehara, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 17, 2018
Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AFSean T Chen, Anne S Hellkamp, Richard C Becker, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 7, 2021
Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID TrialJemi Galani, Hillary Mulder, Frank W Rockhold, et al.
JACC. Cardiovascular Interventions|July 25, 2020
The Impact of Coronary Physiology on Contemporary Clinical Decision MakingNorihiro Kogame, Masafumi Ono, Hideyuki Kawashima, et al.
Pageof 65